Virtuoso™ ICDs¹

with Conexus™ Wireless Telemetry

[+] Click to enlarge

Orchestrated Care
The first complete system to assist in managing heart disease*

Adaptive Therapies
Essential Insight
Wireless Connectivity

What if you could provide proactive care before the onset of heart failure problems?

The Virtuoso Family of ICDs with Conexus Wireless Telemetry signals a new era in managing tachycardia.

Potentially more efficient case management
In addition to innovative therapies and advanced diagnostics Virtuoso ICDs provide:

• Remote patient monitoring with Medtronic CareLink^® Network for more efficient chronic disease management.
• Medtronic CareAlert™ Notification enabling you to quickly identify patients who need attention.

*Virtuoso™ ICDs with Conexus™ Wireless Telemetry, Medtronic CareLink programmer and Medtronic CareLink Network, Model 27901 Conexus Activator

**Beginning of Service
*** Recommended Replacement Time

Adaptive Therapies to monitor and ensure therapy when needed

Fewer Shocks with ATP During Charging^4,5

• Eliminates 3 out of 4 shocks with no delay to definitive therapy.
• Improve patient quality of life with Medtronic PainFREE therapy.⁶
• Potentially improves device longevity.
• Reduce calls to the clinic and clinic work load due to post shock care⁵

ATP During Charging

View Animation

• High (cable/dsl)

This animation requires the latest version of the Macromedia Flash Player. Get player

Pace Less with MVP^™ Managed Ventricular Pacing Mode
(Dual Chamber only)
(play animation)

• Reduces unnecessary RV Pacing by 99% (median)⁷.
• Universal pacing mode that adapts to patient’s needs
• Operates in AAI(R) mode with the added safety of ventricular back-up pacing when needed.

Essential Insight for more informed disease management

New Era of Telemedicine
- know which patients need a follow-up call and why.

Care Alert Notifications
with Conexus Wireless Telemetry

View Animation

• High (cable/dsl)

This animation requires the latest version of the Macromedia Flash Player. Get player

Physician-selected Medtronic CareAlert Notifications provide your staff with a "management by exception" system based on objective data to potentially achieve better, more efficient case management.

OptiVol™ Fluid Status Monitoring

Now available for your ICD patients.

View Animation

• High (cable/dsl)

This animation requires the latest version of the Macromedia Flash Player. Get player

OptiVol Fluid Status Monitoring Provides Unprecendented Insight into Patients' Clinical Status.

• Lung congestion is a major complication in heart failure patients. ^8-9
• OptiVol allows you to continually track your patients’ fluid status using intrathoracic impedance.
• Provides trending data to adjust medical treatment for patients at risk of acute decompensated heart failure.
• Available on Medtronic CareLink Network enabling you to check on your patient’s fluid status from their home.

Cardiac Compass^® Trends Report

[+] Enlarge View

The Cardiac Compass Trends Report provides 14 months of trended information presented in a temporally aligned format for easy assessment of changes across multiple dimensions.

• OptiVol Fluid Status Monitoring
• VT/VF Arrhythmia Information
• AT/AF Arrhythmia Information (Duel Chamber Only)
• Pacing Information
• Heart Failure Information

Advanced Detection Algorithm and Mechanical Specifications

References

1. Medtronic Virtuoso ICDs Implant and Reference Manuals.
2. 50% atrial and 5% ventricular pacing in MVP Mode at 60 ppm, 3 V, 0.4 ms, 500 ohms; pre-arrhythmia EGM storage on; 2 full energy charges per year. Programming pre-arrhythmia EGM to “off” increases longevity by 23% or 2.8 months per year.
3. 15% VVI at 60 ppm, 3 V, 0.4 ms, 500 ohms; pre-arrhythmia EGM storage on; 2 full energy charges per year. Programming pre-arrhythmia EGM to “off” increases longevity by 27% or 3.3 months per year.
4. Wathen MS, Sweeney MO, DeGroot PJ, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation. August 14, 2001;104(7):796-801.
5. Wathen MS, DeGroot PJ, Sweeney MO, et. al., for the PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators. Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial results. Circulation. 2004;110:2591-2596.
6. Ahmad M, Bloomstein L, Roehlke M, Bernstein AD, Parsonnet V. Patients' attitudes toward implanted defibrillator shocks. PACE. June 2000;23(6):934-938.
7. Sweeney MO, Ellenbogen KA, Casavant D, et al. Multicenter, prospective randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs. J Cardiovasc Electrophysiol. 2005;16:811-817.
8. Gheorghiade M, Gattis W, O'Connor C, et al. Effects of Tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure. JAMA. 2004;291:1963-1971.
9. 7 Gattis W, O'Connor C, Gallup D, et al. Predischarge initiation of Carvedilol in patients hospitalized for decompensated heart failure. J Am Coll Cardiol. 2004;43:1534-1541.

©Medtronic, Inc. 2008                                                   • Contact Medtronic • Privacy Statement • Terms of Use • Site Map